PEOPLE - Changes at CardioDynamics:
This article was originally published in Clinica
Impedance cardiography specialist CardioDynamics (San Diego, California) has appointed Lynne Parshall and Robert Keith to the board of directors. The company will benefit from their financial, marketing and healthcare experience, said CEO Michael Perry. CardioDynamics is the developer and manufacturer of the BioZ noninvasive, digital cardiac function monitor.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.